| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 19, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market prescription Ibuprofen...
-
Jun 24, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the- counter (OTC)...
-
Jun 16, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has adopted a written trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 to facilitate the repurchase of...
-
May 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter and nine months of fiscal 2005 ended March 26, 2005. Perrigo Company (in thousands, except per share...
-
Apr 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Naproxen Tablets USP, 250...
-
Apr 28, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter on Thursday, May 5, 2005 at approximately 8:30 a.m. (ET). The Company will...
-
Apr 26, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock over the next 12 months....
-
Apr 22, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on June 21, 2005 to shareholders of record on...
-
Apr 11, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Agis Industries subsidiary has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market...
-
Mar 17, 2005Creates global provider of generic prescription drugs, active pharmaceutical ingredients and consumer healthcare products
The Perrigo Company (NASDAQ: PRGO) today announced the completion of its acquisition of Agis Industries (1983) Ltd., a developer and manufacturer of specialized generic pharmaceuticals and active...
-
Mar 15, 2005
The Perrigo Company (NASDAQ: PRGO) announced today that its shareholders approved the issuance of shares of Perrigo common stock in connection with the November 14, 2004 agreement and plan of...
-
Feb 4, 2005
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on March 22, 2005 to shareholders of record on February 25,...
-
Feb 1, 2005
The Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months of fiscal 2005 ended Dec. 25, 2004. Perrigo Company (in thousands, except per share amounts) Second...
-
Jan 28, 2005
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter on Tuesday, Feb. 1, 2005 at approximately 8:30 a.m. (ET). The Company will conduct a...
-
Nov 3, 2004
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a technology-based specialty pharmaceuticals and drug delivery company, and Perrigo Company (NASDAQ: PRGO), the nation's largest manufacturer of...
-
Oct 29, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on December 21, 2004 to shareholders of record on November...
-
Oct 26, 2004
The Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2005 ended Sept. 25, 2004. Perrigo Company (In thousands, except per share amounts) Fiscal 2005 Fiscal...
-
Oct 20, 2004
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its first quarter on Tuesday, October 26, 2004 at approximately 8:30 a.m. (ET). The Company will conduct a...
-
Oct 5, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polacrilex gum and...
-
Aug 10, 2004
The Perrigo Company (NASDAQ: PRGO) today announced results for the full year and fourth quarter ended June 26, 2004. Perrigo Company (in thousands, except per share amounts) Fourth Quarter...
-
Aug 6, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.035 per share, payable on September 21, 2004, to shareholders of record on August...
-
Aug 4, 2004
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fourth quarter and year-end on Tuesday, August 10, 2004 at approximately 8:30 a.m. (ET). The Company...
-
Aug 3, 2004
Today the Perrigo Company (NASDAQ: PRGO) announced that it is negotiating a settlement with the U.S. Federal Trade Commission (FTC) in order to close the FTC's investigation into a 1998 agreement...
-
Jul 15, 2004
The Perrigo Company (NASDAQ: PRGO) announced today that it has entered into a purchase agreement to acquire certain assets of APG, Inc., a privately-owned contract manufacturer and packager of...
-
Jun 10, 2004
The Perrigo Company (NASDAQ: PRGO) said today that it had completed a review of the May 2004 contract between Lannett Company, Inc. (AMEX: LCI) and Jerome Stephens Pharmaceutical, Inc. (JSP). As...